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Association of chronic kidney graft failure with recipient blood pres-
sure. Immunological rejection is the most important cause of kidney
transplant failure. Recently, nonimmunological causes of long-term allo-
graft failure have become more widely appreciated. In primary chronic
renal disease, blood pressure is of overriding importance for long-term
renal function. The role of blood pressure in determining long-term
transplant outcome has not yet been established. We studied the influence
of blood pressure post-transplantation on long-term kidney graft outcome
in 29,751 patients. Outpatient blood pressure measurements were re-
corded and reported to the Collaborative Transplant Study. Graft and
patient survival rates were analyzed over seven years in relation to blood
pressure. Increased levels of systolic and diastolic blood pressure post-
transplantation were associated with a graded increase of subsequent graft
failure (P , 0.0001). Chronic graft failure was significantly associated with
blood pressure even when patient death was censored (P , 0.0001). Cox
regression analysis established increased blood pressure as an indepen-
dent risk factor for graft failure. We conclude that post-transplant blood
pressure is a highly significant predictor of long-term kidney graft out-
come. Whether aggressive lowering of blood pressure improves long-term
transplant outcome will have to be studied prospectively.
It is generally accepted that immunological rejection is the main
cause of acute and chronic kidney graft failure [1]. Recently,
however, nonimmunological factors such as age, gender and race
have been implicated as risk factors for chronic graft loss [2]. It
was hypothesized that these factors may exert a deleterious
influence because of their association with a reduced nephron
mass, and supportive evidence for this hypothesis was obtained in
experimental animal studies [3]. For many years it has been
known that hypertension is associated with graft failure in renal
transplant recipients, although the nature of this relationship has
not been clearly delineated [4–9]. The risk of graft failure
associated with increased blood pressure has not been quantified
and rational guidelines for optimal levels of treated blood pres-
sure have not been established. In patients with primary chronic
renal disease, the importance of blood pressure for renal function
prognosis has been documented [10, 11] and this relationship
apparently is causal, since the lowering of blood pressure by
means of antihypertensive medication reduces the rate of func-
tional deterioration [12].
In 1988, with the aim of examining the relationship between
blood pressure and long-term graft outcome in a large patient
cohort, we started to include post-transplant blood pressure
measurements into the Collaborative Transplant Study patient
follow-up protocol. Data on 29,751 patients formed the basis for
this analysis.
METHODS
Outpatient blood pressure measurements were obtained at 262
transplant centers and reported to the Collaborative Transplant
Study at yearly intervals after transplantation. Cadaver kidney
transplants performed from 1987 to 1995 were included in this
analysis. Graft and patient survival rates were computed accord-
ing to the method of Kaplan and Meier [13] and statistical
significance was estimated using weighted regression analysis [14].
Multivariate Cox regression analysis [15] was performed to eval-
uate any confounding influence of the following variables: under-
lying renal disease (glomerulonephritis, diabetic nephropathy,
polycystic disease, pyelonephritis, reflux, other), gender (male,
female), race (Caucasian, Black, other), age (. 60, , 61 years),
primary or retransplant, antihypertensive medication other than
diuretics (yes, no), cold ischemic kidney preservation time (, 12,
12 to 24, . 24 hr), HLA-A,-B,-DR match (0, 1 to 3, 4 to 6
mismatches), preformed panel-reactive lymphocytotoxic antibod-
ies (0 to 50%, . 50%), and geographical region (North America,
Europe, other).
RESULTS
There was a striking association between systolic blood pressure
values measured at yearly post-transplant intervals and subse-
quent kidney graft survival (P , 0.0001; Fig. 1). Diastolic blood
pressure was also significantly associated with graft outcome.
Increasing systolic pressure was associated with decreased graft
survival at any level of diastolic blood pressure. Even within the
range considered “normal” for diastolic blood pressure according
to the WHO definition (, 90 mm Hg), a deleterious effect of
increasing systolic pressure was apparent (Fig. 2). Moreover, the
effect of systolic blood pressure on graft outcome could be
documented both in patients who received antihypertensive med-
ication and in patients without such medication (Fig. 3).
To establish whether the deleterious effect of increased blood
pressure was independent of other known risk factors, the data
were analyzed in a multivariate Cox regression model, including
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Fig. 1. Association of systolic blood pressure at
(A) one year, (B) three years and (C) five years
with subsequent graft survival in recipients of
cadaver kidney transplants. Ranges of systolic
blood pressure values in mm Hg and numbers
of patients studied in the subgroups are
indicated. The association of systolic blood
pressure with graft survival at seven years was
statistically highly significant in all three
analyses (regression P , 0.0001).
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Fig. 2. Influence of one-year systolic blood
pressure on long-term graft outcome in a
patient subgroup with a one-year diastolic
blood pressure of < 90 mm Hg (regression P <
0.0001).
Fig. 3. Association of systolic blood pressure at one year with long-term graft outcome in patients with (A) or without (B) anti-hypertensive medication.
The deleterious effect of increased blood pressure on graft outcome was statistically significant in both patient subgroups (regression P , 0.0001).
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the potentially confounding variables listed in the Methods sec-
tion. There was no distorted distribution of the factors among the
patient cohorts grouped according to their systolic or diastolic
blood pressures. Systolic and diastolic pressures were identified as
significant predictors of subsequent graft failure (Fig. 4). In
addition, the variables diabetic nephropathy, Black recipient race,
recipient or donor age . 60, retransplant, cold ischemia . 24
hours, . 0 HLA-A,-B,-DR mismatch, and . 50% preformed
antibodies were identified as independent risk factors for graft
outcome following the first post-transplant year (P , 0.05).
In the graft survival analyses illustrated in Figures 1 and 2,
patient death was counted as graft failure. Because of the known
association of increased blood pressure with patient death in the
general population, a more detailed analysis was performed. Not
surprisingly, systolic blood pressure at one year after transplanta-
tion was significantly associated with the subsequent death rate
(P , 0.0001, data not shown). However, when patient death was
censored and patients dying with functioning grafts were counted
as “lost to follow-up,” the association of functional graft loss with
increased systolic blood pressure was still highly significant (P ,
0.0001; Fig. 5).
In an effort to explore whether increased blood pressure was
merely an indicator of allograft damage due to immunologic
rejection rather than the cause of subsequent functional deterio-
ration, an analysis was carried out in patients who had not
required any treatment of rejection episodes during the first year
after transplantation. Even in this patient subset, the association
of systolic blood pressure with long-term graft outcome was
statistically significant (P , 0.0001; Fig. 6).
DISCUSSION
The results of this analysis are in agreement with our working
hypothesis that recipient blood pressure is an important predictor
of late chronic graft failure. Although such a relationship has long
been suggested [4–9], it has not been formally documented. We
were able to establish that increased blood pressure is significantly
associated with the rate of functional graft loss. It is known that
HLA compatibility affects the rate of long-term graft failure [16].
The interest of the present observation resides in the fact that
blood pressure is another determinant of long-term graft function
that lends itself to intervention, in contrast to other established
predictors such as age, race or gender [2].
In primary renal disease, evolution of renal failure is influenced
by antihypertensive treatment, particularly by the administration
of angiotensin converting enzyme (ACE) inhibitors [17] and some
of the calcium channel blockers [18]. We would like to point out
that during this study, ACE inhibitors were not admitted by the
regulatory authorities in most countries for the treatment of trans-
planted patients. In the current analysis, blood pressure and graft
outcome were associated both in patients with and without antihy-
pertensive medication. That patients with antihypertensive medica-
tion generally had higher graft loss rates is explained by the greater
blood pressure load of patients with a history of treated hypertension.
One could argue that increased blood pressure values are the
result of renal damage induced by acute rejections. The present
study could then be interpreted as confirming reports showing
that documented early rejection episodes are associated with
chronic graft rejection [19, 20]. The separate analysis performed
in recipients who were rejection-free, however, suggests that
hypertension in these patients was not a consequence of the host’s
alloimmune response. Yet, blood pressure was associated with
long-term outcome even in the absence of rejection. This obser-
vation is consistent with the hypothesis of a causal relationship
between increased blood pressure and functional renal damage.
A possible mechanism for the observed effect on chronic graft
failure might be an amplification of immunologically induced
injury by increased blood pressure, similar to the observation of
more severe renal injury when Goldblatt hypertension was super-
imposed upon glomerulonephritis induced by anti-GBM antibod-
ies [21]. The grafted kidney with vasculitic lesions might be
particularly susceptible to such mechanical injury, which might
enhance immune-mediated damage. This hypothesis is in accor-
dance with the finding of Luft and Haller that high blood pressure
activates inflammatory effector mechanisms in renal tissue [22].
Moreover, an accelerated loss of renal function has been noted in
patients with non-inflammatory renal disease, such as autosomal
polycystic kidney disease, who had a genetic predisposition to
essential hypertension [23], suggesting that non-inflammatory
mechanisms might also play a role.
It is remarkable that a highly significant association of chronic
graft failure with blood pressure was obtained even though the
analysis was based on one yearly outpatient blood pressure
measurement. Because of the “white coat effect” and the known
Fig. 4. Result of multivariate Cox regression analysis. Both increased
systolic (A) and increased diastolic (B) blood pressure at one year were
associated with an increased risk of graft failure during the following six
years. Relative risks of failure and P values are indicated for ranges of
systolic and diastolic blood pressure values (*P , 0.0002; **P , 0.0001; †P
, 0.05; #P , 0.01).
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circadian fluctuations in blood pressure, one would not necessarily
have expected unequivocal results from such outpatient blood
pressure data. It is likely that non-representative measurements
obtained in some patients were reduced to “background noise” in
the analysis of this very large patient population. The convincing
graded associations found between chronic graft loss and in-
creased blood pressure values provide a compelling argument for
the study’s overall validity. The associations would probably have
been even stronger had the blood pressure measurements been
performed under strictly standardized conditions.
Apart from providing new insights into the relationship be-
tween increased blood pressure and chronic allograft damage, the
results of this study raise an important practical question: Which
blood pressure is optimal for the renal transplant recipient and
how aggressively should increased blood pressure be lowered by
antihypertensive medication? The data reported to the Collabo-
rative Transplant Study show that in clinical practice, many
patients are maintained at blood pressure values that are associ-
ated with an increased rate of chronic graft loss. As many as 55%
(N 5 16497) of the cadaver transplant recipients studied in this
analysis had a one-year systolic blood pressure of 140 mm Hg or
higher, a value that must be considered too high based on the
present results. We do not know to what extent the frequent
occurrence of high blood pressure was the result of physician-
unawareness of the problem, patient noncompliance, or the
non-availability of modern antihypertensive agents such as ACE
inhibitors. Whether aggressive lowering of blood pressure, if
necessary with combination drug therapy, is a suitable strategy for
reducing the rate of chronic graft failure remains unresolved. One
can assume that the majority of patients with blood pressures
Fig. 5. Analysis of functional graft survival.
Patient death was censored. Association of one-
year systolic blood pressure with subsequent
outcome: regression P , 0.0001.
Fig. 6. Effect of one-year systolic blood
pressure on long-term graft outcome in
patients who did not require treatment for
acute rejection during the first post-transplant
year. The association of increasing blood
pressure values with decreased graft survival
was statistically significant (regression P ,
0.0001).
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associated with an increased risk of chronic graft loss can be
returned to “safe” levels using currently available medication. In
view of the positive results obtained in patients with primary
chronic renal disease, in whom the rate of functional deterioration
was significantly reduced by aggressive blood pressure lowering [12],
we propose that prospective trials of aggressive blood pressure
control are now justified in renal transplant recipients as well.
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APPENDIX
The data for this analysis were provided by transplantation
centers in the following cities:
Argentina: Buenos Aires, Cordoba, Mar del Plata, Santa Fe;
Australia: Adelaide, Brisbane, Heidelberg, Melbourne, Newcastle,
Perth, Sydney; Austria: Innsbruck, Linz, Vienna; Belgium: Brus-
sels, Gent, Leuven, Liege; Brazil: Belo Horizonte, Pato Branco,
Porto Alegre, Ribeirao Preto, Rio de Janeiro, Sao Paulo; Canada:
Calgary, Edmonton, Hamilton, Ottawa, Quebec, Toronto, Van-
couver, Winnipeg; Chile: Santiago de Chile; Colombia: Bogota,
Cali, Medellin; Croatia: Zagreb; Czech Republic: Plzen, Prague;
Egypt: Cairo; Finland: Helsinki; France: Lille, Limoges, Nancy,
Nantes, Nice, Paris, Poitiers, Reims, Rennes, Saint Etienne,
Strasbourg, Toulouse, Tours; Germany: Aachen, Berlin, Bonn,
Bremen, Cologne, Duesseldorf, Erlangen, Essen, Frankfurt,
Freiburg, Giessen, Goettingen, Halle, Hann-Muenden, Heidel-
berg, Homburg, Jena, Kaiserslautern, Kiel, Luebeck, Mainz,
Mannheim, Marburg, Munich, Muenster, Tuebingen, Ulm; Great
Britain: Belfast, Birmingham, Cambridge, Cardiff, Exeter, Glas-
gow, Leicester, London, Nottingham, Oxford, Stoke on Trent;
Greece: Thessaloniki; Hong Kong; Hungary: Budapest, Debrecen,
Pecs, Szeged; Iran: Kermanshah, Mashad, Tehran, Urmia; Iraq:
Baghdad; Italy: Bergamo, Brescia, Genua, Florence, Milan, Padova,
Rome, Treviso, Turin; Japan: Fukui, Fukuoka, Hiroshima, Isehara,
Kashihara, Osaka, Tokorozawa, Ube; Korea: Seoul; Lithuania:
Vilnius; Mexico: Culiacan; Netherlands: Amsterdam, Maastricht, Ni-
jmegen; New Zealand: Christchurch; Pakistan: Karachi; Portugal:
Lisbon; Peru: Lima; Philippines: Manila; Poland: Warsaw; Russia:
Moscow, St. Petersburg; Slovenia: Ljubljana; South Africa: Cape
Town; Spain: Alicante, Baracaldo, Barcelona, Madrid, Malaga,
Oviedo, Pamplona, Santander, Valencia; Sweden: Uppsala; Switzer-
land: Basel, Bern, Geneva, Lausanne, St. Gallen, Zuerich; Tunesia:
Tunis; Turkey: Ankara, Antalya, Izmir; United States of America:
Akron, Albuquerque, Atlanta, Baltimore, Birmingham, Chicago,
Cincinnati, Cleveland, Dallas, Detroit, Grand Rapids, Hartford,
Iowa City, Kansas City, Lexington, Little Rock, Louisville, Minneap-
olis, Nashville, Newark, New Orleans, New York, Oklahoma City,
Omaha, Orlando, Portland, Rochester, San Antonio, Seattle,
Shreveport, Toledo, Valhalla, Washington, Wichita; Venezuela: Ca-
racas, Barquisimeto; Yugoslavia: Novisad.
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